Member

2023 ASHP Pharmacy Practice Sections Election Results

Published: August 4, 2023
2023 ASHP Pharmacy Practice Sections Election Results

ASHP members have selected the following individuals to serve on the Executive Committees of ASHP’s Pharmacy Practice Sections.

The terms for the Section Chairs-elect will begin immediately; the two-year terms for Directors-at-Large will start in June 2024.

The new officers are as follows:

SECTION OF AMBULATORY CARE PRACTITIONERS

Chair (2024-2025)
Sara M. Panella, PharmD, BCPS, CPh
Manager - Pharmacy Ambulatory Care, Population Health and Transitions of Care, Baptist Health South Florida, Clinical Pharmacy Enterprise
Miami Lakes, FL

Director-at-Large (2024-2026)
Daniel B. Truelove, PharmD, AAHIVP, BCACP, BCPS
Director of Pharmacy, University Health Network, University of Tennessee Medical Center
Knoxville, TN

SECTION OF CLINICAL SPECIALISTS AND SCIENTISTS

Chair (2024-2025)
Megan Musselman, PharmD, MS, BCCCP, BCEMP, BCPS, DPLA, FASHP, FCCP
Clinical Pharmacist Specialist, Emergency Medicine and Director, PGY2 Emergency Medicine Residency Program, North Kansas City Hospital
North Kansas City, MO

Director-at-Large (2024-2026)
Megan A. Corrigan, PharmD, MPH, BCPS, FASHP
Director of Pharmacy and Emergency Management, Advocate Good Samaritan Hospital
Downers Grove, IL

SECTION OF COMMUNITY PHARMACY PRACTITIONERS

Chair (2024-2025)
Courtney B. Isom, PharmD, BCACP, CPP
Pharmacy Administrative Coordinator and Director, PGY1 Community-Based Pharmacy Residency Program, Cone Health Community Pharmacy at Wendover Medical Center
Greensboro, NC                      

Director-at-Large (2024-2026)
Thomas G. Wadsworth, PharmD, BCPS
Associate Professor and Interim Dean, Idaho State University College of Pharmacy
Pocatello, ID

SECTION OF INPATIENT CARE PRACTITIONERS

Chair (2024-2025)
Lucas T Schulz, PharmD, BCIDP
Clinical Manager - Infectious Diseases, Solid Organ Transplant, Experiential Education and Pharmacy Practice Advancement, PGY1 Residency Program and PGY2 Infectious Diseases Residency Program Director, UW Health
Madison, WI

Director-at-Large (2024-2026)
Sandeep Devabhakthuni, PharmD, BCCP
Associate Dean of Student Affairs and Associate Professor, University of Maryland School of Pharmacy
Baltimore, MD

SECTION OF PHARMACY EDUCATORS

Chair (2024-2025)
Jennifer D. Arnoldi, PharmD, BCPS
Clinical Professor, Southern Illinois University Edwardsville School of Pharmacy
Edwardsville, IL

Director-at-Large (2024-2026)
Dale E. English II, PharmD, BSPharm, RPh, FASHP
Associate Dean of Student Affairs and Professor of Pharmacy Practice, Sullivan University College of Pharmacy and Health Sciences
Louisville, KY

SECTION OF PHARMACY INFORMATICS AND TECHNOLOGY

Chair (2024-2025)
Jeffrey Chalmers, PharmD
Senior Director, Pharmacy Informatics and Technology, Cleveland Clinic Health System
Cleveland, OH

Director-at-Large (2024-2026)
Casey Olsen, PharmD
Pharmacy Informatics Coordinator, Advocate Health
Downers Grove, IL

SECTION OF PHARMACY PRACTICE LEADERS

Chair (2024-2025)
Katherine (Kat) A. Miller, PharmD, MHA, DPLA, FASHP
Senior Director, Acute Care Pharmacy and Clinical Nutrition, The University of Kansas Health System
Kansas City, KS

Director-at-Large (2024-2026)
Amanda Hansen, PharmD, MHA, FACHE, FASHP
Senior Director of Pharmacy, Cleveland Clinic
Cleveland, OH

SECTION OF SPECIALTY PHARMACY PRACTITIONERS

Chair (2024-2025)
Erica Diamantides, PharmD, MHA, BCPS
System Director, Specialty Pharmacy Services, Tufts Medicine
Boston, MA

Director-at-Large (2024-2026)
Autumn D. Zuckerman, PharmD, BCPS, CSP
Director, Health Outcomes and Research, Vanderbilt Specialty Pharmacy
Nashville, TN

ADVERTISEMENT

Posted August 4, 2023
ADVERTISEMENT

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information